Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Cancer|April 1, 1984
High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myelomaR E Lenhard, M M Oken, J M Barnes, et al.Clinical Science (London, England : 1979)|June 1, 1992
Pernicious anaemia as a risk factor for osteoporosisR Eastell, N E Vieira, A L Yergey, et al.British Journal of Haematology|January 1, 1980
Structure-function of the factor VIII complex studied with an immobilized heteroantisera to VIII:CH A Cooper, D Lee, M A Lamb, et al.The Journal of Clinical Investigation|September 1, 1975
Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragmentH A Cooper, F F Reisner, M Hall, et al.British Journal of Haematology|November 14, 1997
The effects of anagrelide on human megakaryocytopoiesisL A Solberg, A Tefferi, K J Oles, et al.Blood Cells, Molecules & Diseases|January 1, 1996
Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methodsV F Fairbanks, G G Klee, G A Wiseman, et al.Mayo Clinic Proceedings|June 1, 1990
Two families with hemoglobin Sogn, beta(A11)14 Leu----Arg, in Minnesota and Indiana: hematologic, functional, and biosynthetic featuresV F Fairbanks, R T Jones, C Head, et al.Proceedings of the National Academy of Sciences of the United States of America|March 1, 1982
Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factorH A Cooper, W P Bennett, G C White, et al.The Journal of Laboratory and Clinical Medicine|February 1, 1975
Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factorJ P Allain, H A Cooper, R H Wagner, et al.Pageof 8